Add to Calendar Allogeneic Stem Cell Transplantation Rounds 2023-2024 1/4/2024 1:00:00 PM 1/4/2024 2:00:00 PM America/New_York For More Details: https://upenn.cloud-cme.com/course/courseoverview?EID=80281 Description: The primary goal of this series is to provide ongoing educational updates and reviews to our physicians, nurses, and other professional staff to ensure that we are all current with the best practices of allogeneic stem cell transplantation. This series will promote application of the best possible and most up to date therapies and will ensure standardization across our group and minimize variations in ... Perelman Center for Advanced Medicine, Conference Room 12-122 false MM/DD/YYYY


Occurs weekly every Thursday starting on 1/4/2024 at 1:00 PM
Thursday, January 4, 2024, 1:00 PM - 2:00 PM, Perelman Center for Advanced Medicine, Conference Room 12-122, Philadelphia, PA


The primary goal of this series is to provide ongoing educational updates and reviews to our physicians, nurses, and other professional staff to ensure that we are all current with the best practices of allogeneic stem cell transplantation. This series will promote application of the best possible and most up to date therapies and will ensure standardization across our group and minimize variations in care.


Specialties - INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Medical Oncology


Objectives

After completing this activity, participants should be able to:


  1. Identify and discuss from an interprofessional perspective appropriate candidates for transplant based on many factors including infectious disease risks, comorbidity risks, disease specific risk factors. Patient selection will require consideration of many of these disease factors.
  2. Describe the likelihood of developing C. difficile as well as methods to prevent transmission, the unique risks associated with this infection in transplant patients, and list methods that prevent infection including how practice changes effect outcomes.
  3. Describe outcomes after allogeneic stem cell transplantation for patients with refractory AML or advanced MDS, including an outline of new treatment practices that may impact outcomes, and from an interprofessional perspective discuss availabilities of novel clinical trials and outcomes associated with new approaches
  4. Describe differences and potential risks and benefits associated with different donor choices from an interprofessional perspective with an emphasis on developing a consistent approach to donor selection through systematic evaluation of various options.


In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit



AMA PRA Category 1 Credits™ (1.00 hours), ACPE (1.00 hours), American Academy of Physician Assistants (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), Patient Safety/Risk Management PSRM (1.00 hours)